Almanack Investment Partners LLC. bought a new position in shares of iShares Core Conservative Allocation ETF (NYSEARCA:AOK – Get Rating) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 3,000 shares of the company’s stock, valued at approximately $98,000.
Other institutional investors have also recently made changes to their positions in the company. CoreCap Advisors LLC purchased a new position in iShares Core Conservative Allocation ETF during the 2nd quarter valued at approximately $126,000. Cary Street Partners Investment Advisory LLC purchased a new position in iShares Core Conservative Allocation ETF during the 3rd quarter valued at approximately $202,000. Compass Advisory Group LLC purchased a new position in iShares Core Conservative Allocation ETF during the 3rd quarter valued at approximately $231,000. Finally, LFS Asset Management purchased a new position in iShares Core Conservative Allocation ETF during the 2nd quarter valued at approximately $2,247,000.
iShares Core Conservative Allocation ETF Price Performance
NYSEARCA AOK opened at $34.25 on Wednesday. The stock has a market capitalization of $758.64 million, a PE ratio of 14.10 and a beta of 0.37. The business has a 50 day simple moving average of $34.61 and a two-hundred day simple moving average of $33.97. iShares Core Conservative Allocation ETF has a 1-year low of $31.85 and a 1-year high of $37.84.
iShares Core Conservative Allocation ETF Profile
iShares Conservative Allocation ETF, formerly iShares S&P Conservative Allocation Fund (the Fund), is an exchange-traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Target Risk Conservative Index (the Conservative Allocation Index). The Conservative Allocation Index seeks to measure the performance of an asset allocation strategy targeted to a conservative risk profile.
Featured Stories
- Get a free copy of the StockNews.com research report on iShares Core Conservative Allocation ETF (AOK)
- Monoclonal Antibodies? Avid Bioservices surges 32% on Blowout Q3
- GitLab Crashes On Guidance; Analysts Defend
- Healthcare Stocks With at Least 30 Years of Dividend Increases
- Coinbase Pops As SVB Crumbles To Dust
- Airlines Update Guidance, Shares Head For Different Destinations
Want to see what other hedge funds are holding AOK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Core Conservative Allocation ETF (NYSEARCA:AOK – Get Rating).
Receive News & Ratings for iShares Core Conservative Allocation ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Core Conservative Allocation ETF and related companies with MarketBeat.com's FREE daily email newsletter.
